ARID1A and non-small cell lung carcinoma: Thus, the mutual exclusive interaction described here provides additional independent confirmation of the relevance of the functional link between ARID1A and EGFR/MAPK-pathway during tumor progression in CRC and NSCLC patients that are EGFR signaling dependent that is consistent with previously published genetic data in NSCLC cell lines.